Anomalies in conventional T and invariant natural killer T-cell populations in Fabry mice but not in Fabry patients

被引：12
|
作者：
Balreira, Andrea [1 ,2 ]
Macedo, Maria F. [1 ]
Girao, Cristina [1 ]
Rodrigues, Lorena G. [1 ]
Oliveira, Joaa P. [3 ]
Miranda, Maria Clara Sa [1 ]
Arosa, Fernando A. [1 ,2 ]
机构：
[1] Univ Porto, IBMC, P-4100 Oporto, Portugal
[2] Univ Porto, ICBAS, P-4100 Oporto, Portugal
[3] Hosp Sao Joao, Serv Genet, Oporto, Portugal
来源：
BRITISH JOURNAL OF HAEMATOLOGY | 2008年 / 143卷 / 04期
关键词：
T cells; natural killer T cells; lipids; major histocompatibility complex; disease;
D O I：
10.1111/j.1365-2141.2008.07380.x
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：601 / 604
页数：5
相关论文
共 50 条
  • [1] Anomalies in T and iNKT populations in Fabry mice but not in Fabry patients
    Balreira, A.
    Macedo, M. F.
    Girao, C.
    Rodrigues, L. G.
    Oliveira, J. P.
    Sa, Miranda M. C.
    Arosa, F. A.
    [J]. JOURNAL OF INHERITED METABOLIC DISEASE, 2008, 31 : 104 - 104
  • [2] Dysregulation of invariant natural killer T cells levels in a large cohort of Fabry disease patients
    Pachcinski, Olaf
    Martinez, David Moreno
    Hughes, Derralynn
    [J]. MOLECULAR GENETICS AND METABOLISM, 2023, 138 (02) : 99 - 100
  • [3] Invariant natural killer T cells are phenotypically and functionally altered in Fabry disease
    Pereira, Catia S.
    Azevedo, Olga
    Luz Maia, M.
    Dias, Ana F.
    Sa-Miranda, Clara
    Fatima Macedo, M.
    [J]. MOLECULAR GENETICS AND METABOLISM, 2013, 108 (04) : 241 - 248
  • [4] Enzyme replacement therapy partially prevents invariant Natural Killer T cell deficiency in the Fabry disease mouse model
    Macedo, Maria Fatima
    Quinta, Rui
    Pereira, Catia Sofia
    Sa Miranda, Maria Clara
    [J]. MOLECULAR GENETICS AND METABOLISM, 2012, 106 (01) : 83 - 91
  • [5] Defective Invariant Natural Killer T-Cell Suppression in Patients With Type 1 Diabetes
    Nel, Isabelle
    Lehuen, Agnes
    [J]. DIABETES, 2016, 65 (08) : 2121 - 2123
  • [6] Invariant natural killer T cell-mediated cytokine secretion is a potential biomarker to monitor the efficacy of treatment for Fabry disease
    Gwalani, Lavesh
    Chi, Joshua
    Wu, Rui
    Dalrymple, Margaret
    Palliser, Deborah
    [J]. MOLECULAR GENETICS AND METABOLISM, 2021, 132 (02) : S46 - S46
  • [7] Control of early stages in invariant natural killer T-cell development
    Hu, Taishan
    Gimferrer, Idoia
    Alberola-Ila, Jose
    [J]. IMMUNOLOGY, 2011, 134 (01) : 1 - 7
  • [8] T-cell dysfunction in natural killer/T-cell lymphoma
    Feng, Xiaoyan
    Meng, Miaomiao
    Li, Hongwen
    Gao, Yuyang
    Song, Wenting
    Di, Ruiqing
    Li, Zhaoming
    Zhang, Xudong
    Zhang, Mingzhi
    [J]. ONCOIMMUNOLOGY, 2023, 12 (01):
  • [9] Profound invariant natural killer T-cell deficiency in inflammatory arthritis
    Tudhope, Susan J.
    von Delwig, Alexei
    Falconer, Jane
    Pratt, Arthur
    Woolridge, Tom
    Wilson, Gillian
    Isaacs, John D.
    Ng, Wan-Fai
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2010, 69 (10) : 1873 - 1879
  • [10] Role of cytolytic impairment of natural killer and natural killer T-cell populations in rheumatoid arthritis
    Aggarwal, Ashish
    Sharma, Aman
    Bhatnagar, Archana
    [J]. CLINICAL RHEUMATOLOGY, 2014, 33 (08) : 1067 - 1078
12345